Syneos Health announced the completion of its acquisition by a consortium of private investment firm affiliates composed of Elliott Investment Management L.P., Patient Square Capital and Veritas Capital. As a result of the transaction, Syneos Health is now a privately held company. With the support of its new private investors, the Company will be poised to further accelerate its transformation, fuel investments in technology that better differentiate its integrated solutions and expand its commitment to better serve customers. Under the terms of the transaction, Syneos Health stockholders will receive $43.00 in cash for each share of Syneos Health common stock they hold. The transaction was originally announced on May 10, 2023, and received approval from Syneos Health stockholders on August 2, 2023. As a result of the completion of the transaction, shares of Syneos Health common stock were removed from listing on the Nasdaq Stock Market, with trading in Syneos Health shares suspended prior to the opening of business today.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SYNH:
- Syneos Health Closes Transaction with Private Investment Firms
- Civitas Resources to replace Syneos Health in S&P 400 at open on 9/29
- Syneos Health appoints Terttu Haring as president, clinical sites & patients
- Syneos Health and Oracle to Expand Relationship to Accelerate Patient Recruitment & Advance Health Equity
- Syneos Health, Oracle expand relationship to accelerate patient recruitment
